Healthtech startup Kyruus doubled its revenue in 2017, and with $10 million in fresh funding, it’s showing no signs of stopping.
On Thursday, the startup announced the round, which included investments from Venrock, Providence, New Leaf, McKesson, Lux Capital, Leerink, Highland and F-Prime.
“In recent years, patient access has become a top strategic priority for health systems across the country with growing attention at the C-level," said Co-Founder and Chief Product Officer Julie Yoo. "Key market trends such as healthcare’s digital transformation, rising consumerism in healthcare, and a growing focus on patient experience have all bolstered this. Health systems are increasingly recognizing the win-win that improving access delivers for their patients and their organizations – and investing in technology to do so.”
This round brings the startup’s total funding amount up to $72 million. Its last round of funding was a $25 million Series C in 2015.
Currently, a number of patients are forced to wait weeks or months for doctors appointments, and Kyruus helps connect patients and providers to reduce the wait time. The platform matches patients with the right providers, which leads to better, more immediate care.
With this funding, the startup plans to grow its product development and delivery teams to expand its platform, as well as integrate with other leaders in the industry.
“We’re focused on expanding our role in the evolving digital health ecosystem by operationalizing our partnerships and forming new ones,” said Yoo.
